海量图书期刊资源,随时随地畅享阅读乐趣
Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147Phipps, Amanda I.; Shi, Qian; Limburg, Paul J.; Nelson, Garth D.; Sargent, Daniel J.; Sinicrope, Frank A.; Chan, Emily; Gill, Sharlene; Goldberg, Richard M.; Kahlenberg, Morton; Nair, Suresh; Shields, Anthony F.; Newcomb, Polly A.; Alberts, Steven R. · International Journal of Cancer · 2016
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patientsLee, Adam M.; Shi, Qian; Alberts, Steven R.; Sargent, Daniel J.; Sinicrope, Frank A.; Berenberg, Jeffrey L.; Grothey, Axel; Polite, Blase; Chan, Emily; Gill, Sharlene; Kahlenberg, Morton S.; Nair, Suresh G.; Shields, Anthony F.; Goldberg, Richard M.; Diasio, Robert B. · Pharmacogenetics and Genomics · 2016
Physical activity and outcomes in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance)Phipps, Amanda I.; Shi, Qian; Zemla, Tyler J.; Dotan, Efrat; Gill, Sharlene; Goldberg, Richard M.; Hardikar, Sheetal; Jahagirdar, Balkrishna; Limburg, Paul J.; Newcomb, Polly A.; Shields, Anthony; Sinicrope, Frank A.; Sargent, Daniel J; Alberts, Steven R · Cancer Epidemiology Biomarkers & Prevention · 2018
Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147Huang, Jocelin; Nair, Suresh G.; Mahoney, Michelle R.; Nelson, Garth D.; Shields, Anthony F.; Chan, Emily; Goldberg, Richard M.; Gill, Sharlene; Kahlenberg, Morton S.; Quesenberry, James T.; Thibodeau, Stephen N.; Smyrk, Thomas C.; Grothey, Axel; Sinicrope, Frank A.; Webb, Thomas A.; Farr, Gist H.; Pockaj, Barbara A.; Berenberg, Jeffrey L.; Mooney, Margaret; Sargent, Daniel J.; Alberts, Steven R. · Clinical Colorectal Cancer · 2014
LBA-010Prognostic utility of immune markers and validation of Immunoscore in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance)Sinicrope Frank, A; Shi, Qian; Hermitte, Fabienne; Heying, Erica; Benson Al, B; Gill, Sharlene; Goldberg Richard, M; Kahlenberg, Morton; Nair, Suresh; Shields, Anthony; Sargent, Dan; Galon, Jérôme; Alberts Steven, R · Annals of Oncology · 2017
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiativeCohen, Romain; Vernerey, Dewi; Bellera, Carine; Meurisse, Aurélia; Henriques, Julie; Paoletti, Xavier; Rousseau, Benoît; Alberts, Steven; Aparicio, Thomas; Boukovinas, Ioannis; Gill, Sharlene; Goldberg, Richard M.; Grothey, Axel; Hamaguchi, Tetsuya; Iveson, Timothy; Kerr, Rachel; Labianca, Roberto; Lonardi, Sara; Meyerhardt, Jeffrey; Paul, James; Punt, Cornelis J.A.; Saltz, Leonard; Saunders, Marck P.; Schmoll, Hans-Joachim; Shah, Manish; Sobrero, Alberto; Souglakos, Ioannis; Taieb, Julien; Takashima, Atsuo; Wagner, Anna Dorothea; Ychou, Marc; Bonnetain, Franck; Gourgou, Sophie; Yoshino, Takayuki; Yothers, Greg; de Gramont, Aimery; Shi, Qian; André, Thierry · European Journal of Cancer · 2020
Breast cancer screening in young womenNature Clinical Practice Oncology · 2005
Evolving paradigms and perceptions of cancerHellman, Samuel · Nature Clinical Practice Oncology · 2005
Shifting paradigms in lung cancerDeVita, Vincent T · Nature Clinical Practice Oncology · 2005
Can lifestyle influence genetics?Karlan, Beth Y · Nature Clinical Practice Oncology · 2007
The conundrum of fluoroquinolone prophylaxisFreifeld, Alison; Sepkowitz, Kent · Nature Clinical Practice Oncology · 2006
Neuroblastic tumors and the epigenomeKirby, Ruth · Nature Clinical Practice Oncology · 2005
Hyaluronan levels and endometrial cancer progressionLovegrove, Carol · Nature Clinical Practice Oncology · 2005
The clinical trials system is brokenDeVita, Vincent T · Nature Clinical Practice Oncology · 2008